High level accumulation of EPA and DHA in field‐grown transgenic Camelina – a multi‐territory evaluation of TAG accumulation and heterogeneity. Issue 11 (8th May 2020)

• Record Type: Journal Article
• Authors: Han, Lihua; Usher, Sarah; Sandgrind, Sjur; Hassall, Kirsty; Sayanova, Olga; Michaelson, Louise V.; Haslam, Richard P.; Napier, Johnathan A.
• Is Part Of: Plant biotechnology journal. Volume 18:Issue 11(2020)
• Page Start: 2280
• Page End: 2291
• Publication Date: 2020-05-08
• Subjects: omega‐3 -- Camelina -- metabolic engineering -- GM field trials; Plant biotechnology -- Periodicals; Plant genetic engineering -- Periodicals; 630.272
• DOI: 10.1111/pbi.13385
• Languages: English
• ISSNs: 1467-7644

Abstract

Abstract: The transgene‐directed accumulation of non‐native omega‐3 long chain polyunsaturated fatty acids in the seed oil of Camelina sativa (Camelina) was evaluated in the field, in distinct geographical and regulatory locations. A construct, DHA2015.1, containing an optimal combination of biosynthetic genes, was selected for experimental field release in the UK, USA and Canada, and the accumulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) determined. The occurrence of these fatty acids in different triacylglycerol species was monitored and found to follow a broad trend irrespective of the agricultural environment. This is a clear demonstration of the stability and robust nature of the transgenic trait for omega‐3 long chain polyunsaturated fatty acids in Camelina. Examination of non‐seed tissues for the unintended accumulation of EPA and DHA failed to identify their presence in leaf, stem, flower, anther or capsule shell material, confirming the seed‐specific accumulation of these novel fatty acids. Collectively, these data confirm the promise of GM plant‐based sources of so‐called omega‐3 fish oils as a sustainable replacement for oceanically derived oils.